openPR Logo
Press release

Coronavirus (COVID 19) Vaccine Market to Witness Huge Growth and Business Opportunities

01-08-2021 06:16 AM CET | Health & Medicine

Press release from: MarketReportsOnline

Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020

Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020

“Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” provides a comprehensive analysis of the fast-evolving, high-growth global Coronavirus (COVID 19) vaccine market. The report offers the most up-to-date industry data on the actual market situation for the Coronavirus (COVID 19) vaccine.

Get Free Sample Copy at https://www.marketreportsonline.com/contacts/requestsample.php?name=802017.

The report explores a detailed analysis of the introduction of the coronavirus, pathogen characteristics, signs and symptoms, transmission, and prevention. It also evaluates the vaccines developed against MERS-CoV and SARS-CoV. The report reviews a clear insight into the funding of the Coronavirus (COVID-19) vaccine research. The report also offers comprehensive information about the recruiting clinical trials statement by phase, trial status, study sponsor name, and study phase. The report investigates detailed insights about countries, territories, or areas with reported laboratory-confirmed Coronavirus (COVID-19) cases and deaths. Key trends in terms of collaboration and partnership deals are analyzed with details.

The report concludes with the profiles of the key vaccine developers in the global coronavirus vaccine market. The key players are evaluated on the various parameters such as business overview, promising vaccine in clinical development, and recent development.

Report Scope:

Extensive coverage of the Coronavirus (COVID-19) vaccine under development

Detailed Insights of the Introduction, Pathogen Characteristics, Signs and Symptoms, Transmission and Prevention

Provides Comprehensive Insights on the Funding of the Coronavirus (COVID-19) Vaccine Research

Thoroughly Evaluates Vaccines Developed Against MERS-CoV and SARS-CoV

Reviews Most Recent Clinical Trials of the Coronavirus Vaccines

Scrutinizes Countries, Territories or Areas with Reported Laboratory-Confirmed Coronavirus (COVID-19) Cases and Deaths

Provides Key Trends with Respect to Collaboration and Partnership Deals

An Insightful Analysis of the Key Vaccine Developers Along with the Analysis of their Promising Vaccines in the Clinical Development, Phase, Platform Technology, and Recent Development

Key Vaccine Developers Covered in the Report
• University of Oxford
• Clover Biopharmaceuticals/Dynavax/GlaxoSmithKline
• Heat Biologics Inc./University of Miami
• Inovio Pharmaceuticals Inc
• Janssen Pharmaceutical
• Sanofi Pasteur/GlaxoSmithKline (GSK)
• Moderna/NIAID
• Novavax
• Sanofi Pasteur/Translate Bio Inc.
• Vaxart Inc.
• Altimmune
• Medicago
• BioNTech/Pfizer/Fosun Pharma
• GeoVax/BravoVax
• Arcturus Therapeutics/Duke-NUS
• CanSino Biological Inc/Beijing Institute of Biotechnology
• Takis Biotech/Applied DNA Sciences/Evvivax
• Cobra Biologics/Karolinska Institute
• Zydus Cadila
• Codagenix/Serum Institute of India
• Greffex
• ExpreS2ion Biotechnologies ApS
• Vaxil Bio Therapeutics
• Flow Pharma Inc
• AJ Vaccines
• Generex Biotechnology/EpiVax
• Immunomic Therapeutics/EpiVax/PharmaJet
• iBio Inc/CC-Pharming Ltd/Infectious Disease Research Institute
• VIDO-InterVac/University of Saskatchewan/International Vaccine Institute
• Tonix Pharmaceuticals/Southern Research
• IAVI/Batavia Biosciences
• Curevac
• Imophoron Ltd/University of Bristol
• BioNet Asia
• Sinovac/Dynavax
• BIOCAD
• University of Pittsburgh

Purchase a copy of this report at https://www.marketreportsonline.com/contacts/purchase.php?name=802017.

Few Points from List of Tables Covered in Coronavirus (COVID 19) Vaccine Market Report:
Table 4–1: Vaccines Developed Against MERS-CoV
Table 5–1: Vaccines Developed Against SARS-CoV
Table 7–1: Countries, Territories or Areas with Reported Laboratory-Confirmed Coronavirus (COVID-19) Cases and Deaths
Table 9–1: University of Oxford Promising Coronavirus Vaccines in the Clinical Development
Table 9–2: Clover Biopharmaceuticals/Dynavax/GSK Promising Coronavirus Vaccines in the Clinical Development
Table 9–3: Heat Biologics Inc/University of Miami Promising Coronavirus Vaccines in the Clinical Development
Table 9–4: Inovio Pharmaceuticals Inc Promising Coronavirus Vaccines in the Clinical Development
Table 9–5: Janssen Pharmaceutical Promising Coronavirus Vaccines in the Clinical Development
Table 9–6: Sanofi Pasteur/GlaxoSmithKline (GSK) Promising Coronavirus Vaccines in the Clinical Development
Table 9–7: Moderna/NIAID Promising Coronavirus Vaccines in the Clinical Development
Table 9–8: Novavax Promising Coronavirus Vaccines in the Clinical Development
Table 9–9: Sanofi/Translate Bio Promising Coronavirus Vaccines in the Clinical Development
Table 9–10: Vaxart Inc. Promising Vaccines in the Clinical Development
Table 9–11: Altimmune Promising Coronavirus Vaccines in the Clinical Development
Table 9–12: Medicago Promising Coronavirus Vaccines in the Clinical Development
Table 9–13: BioNTech/Pfizer/Fosun Pharma Promising Coronavirus Vaccines in the Clinical Development
Table 9–14: GeoVax/BravoVax Promising Coronavirus Vaccines in the Clinical Development
Table 9–15: Arcturus Therapeutics/Duke-NUS Promising Coronavirus Vaccines in the Clinical Development
Table 9–16: CanSino Biological Inc/ Beijing Institute of Biotechnology Promising Coronavirus Vaccines in the Clinical Development

Inquiry more before buying this report at https://www.marketreportsonline.com/contacts/inquirebeforebuying.php?name=802017.

Phone: + 1 888 391 5441
Email: sales@marketreportsonline.com

MarketReportsOnline.com is your one stop market research and industry analysis reports' library providing business data and intelligence information on thousands of micro markets with global as well as regional coverage. Category focused research, country reports, company profiles, regional and global industry profiles and guides to premium reports offering extensive coverage of other 20+ industries are all available in our library of syndicated market research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Coronavirus (COVID 19) Vaccine Market to Witness Huge Growth and Business Opportunities here

News-ID: 2222165 • Views:

More Releases from MarketReportsOnline

US Lettuce & Chicory Market Key Players, Exports & Imports, Size, Share, Demands …
The US lettuce and chicory market is forecasted to reach US$5.09 billion in 2026, experiencing growth at a CAGR of 2.62% during the period spanning from 2022 to 2026. Growth in the lettuce and chicory market is supported by factors such as rising population, rising middle class spending, shift towards veganism/ vegetarianism, increasing awareness regarding the health benefit of chicory and rising social media influence. However, the market growth is
Global Breast Biopsy Market - Hologic, Danaher Corporation, Becton, Dickinson & …
The global breast biopsy market is forecasted to reach US$1.75 billion in 2025, experiencing growth at a CAGR of 8.56% for the period spanning 2022-202. Growth in the global breast biopsy market was supported by factors such as increasing prevalence of breast cancer and rising female population aged 65 or above. Growing adoption of liquid biopsy is likely to have a positive impact on the global breast biopsy market. However,
Global Contract Development & Manufacturing Organization Market - Catalent, Inc. …
The global Contract Development & Manufacturing Organization (CDMO) market is estimated to reach US$246.6 billion in 2026, growing at a CAGR of 9.31%, for the period spanning 2022-2026. The factors such as increasing per capita disposable income, increasing global healthcare expenditure, rising aging population, increasing R&D spending, growing number of new drugs, rise in investments and strategic collaborations and growing demand for pharmaceutical products are expected to drive the market.
Korean Gaming Market (Mobile, PC and Console) - Netmarble, Pearl Abyss, NCSoft, …
The Korean gaming market is anticipated to reach US$20.98 billion in 2026, growing at a CAGR of 6.21% during the period spanning 2022-2026. After the U.S., China, and Japan, it is the fourth largest market, accounting for more than 6% of the worldwide gaming industry in 2021. The growth in the market has been driven by factors like rising smartphone penetration, rapid urbanization, rising gaming subscribers' penetration rate, expansion of MMORPGs,

All 5 Releases


More Releases for Vaccine

Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%. An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the